313 related articles for article (PubMed ID: 28415770)
1. Human 8-oxoguanine DNA glycosylase gene polymorphism (Ser326Cys) and cancer risk: updated meta-analysis.
Kang SW; Kim SK; Park HJ; Chung JH; Ban JY
Oncotarget; 2017 Jul; 8(27):44761-44775. PubMed ID: 28415770
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.
Guo CL; Han FF; Wang HY; Wang L
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1443-8. PubMed ID: 22526153
[TBL] [Abstract][Full Text] [Related]
3. Association of the hOGG1 Ser326Cys polymorphism with gynecologic cancer susceptibility: a meta-analysis.
Shi Y; Xu W; Zhang X
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33210702
[TBL] [Abstract][Full Text] [Related]
4. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
[TBL] [Abstract][Full Text] [Related]
5. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma.
Zhang J; Zhou J; Zhang P; Wang W; Tao S; Wang M
PLoS One; 2013; 8(6):e65742. PubMed ID: 23762419
[TBL] [Abstract][Full Text] [Related]
9. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
Xu Z; Yu L; Zhang X
Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between the hOGG1 gene Ser326Cys polymorphism and gastric cancer risk: evidence from a case-control study and a meta-analysis.
Hu WG; Pan RJ; Cai W; Wang ZT; Zhu ZG
Genet Mol Res; 2015 Nov; 14(4):14670-9. PubMed ID: 26600527
[TBL] [Abstract][Full Text] [Related]
11. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.
Wei B; Zhou Y; Xu Z; Xi B; Cheng H; Ruan J; Zhu M; Hu Q; Wang Q; Wang Z; Yan Z; Jin K; Zhou D; Xuan F; Huang X; Shao J; Lu P
PLoS One; 2011; 6(11):e27545. PubMed ID: 22114677
[TBL] [Abstract][Full Text] [Related]
12. Association of Base Excision Repair Gene hOGG1 Ser326Cys Polymorphism with Susceptibility to Cervical Squamous Cell Carcinoma and High-Risk Human Papilloma Virus Infection in a Chinese Population.
Chen H; Wang H; Liu J; Cheng Q; Chen X; Ye F
Genet Test Mol Biomarkers; 2019 Feb; 23(2):138-144. PubMed ID: 30648893
[TBL] [Abstract][Full Text] [Related]
13. HOGG1 Ser326Cys polymorphism and susceptibility to head and neck cancer: a meta-analysis.
Liu J; Cao XL; Zhang Z; Lei DP; Jin T; Yu XM; Pan XL
Asian Pac J Cancer Prev; 2011; 12(10):2491-4. PubMed ID: 22320944
[TBL] [Abstract][Full Text] [Related]
14. An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.
Ji C; Liu Z; Chen H; Guo H; Liu C
BMC Cancer; 2012 Aug; 12():335. PubMed ID: 22857644
[TBL] [Abstract][Full Text] [Related]
15. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
Li H; Hao X; Zhang W; Wei Q; Chen K
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
[TBL] [Abstract][Full Text] [Related]
16. The functional Ser326Cys polymorphism in hOGG1 is associated with gastric cancer risk: evidence from 1180 cases and 2444 controls.
Ni M; Qiu J; He W; Wang X
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):683-7. PubMed ID: 22343785
[TBL] [Abstract][Full Text] [Related]
17. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.
Zhang H; Xu Y; Zhang Z; Li L
BMC Cancer; 2011 Sep; 11():391. PubMed ID: 21914193
[TBL] [Abstract][Full Text] [Related]
18. Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis.
Coppedè F; Mancuso M; Lo Gerfo A; Carlesi C; Piazza S; Rocchi A; Petrozzi L; Nesti C; Micheli D; Bacci A; Migliore L; Murri L; Siciliano G
Neurosci Lett; 2007 Jun; 420(2):163-8. PubMed ID: 17531381
[TBL] [Abstract][Full Text] [Related]
19. [Meta analysis of association between Ser326Cys polymorphism of hOGG1 gene and risk of lung cancer].
Qian Q; Liu R; Lei Z; You J; Zhou Q; Zhang HT
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):205-10. PubMed ID: 21426661
[TBL] [Abstract][Full Text] [Related]
20. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis.
Geng P; Yao J; Zhu Y
Mol Biol Rep; 2014; 41(4):2299-306. PubMed ID: 24435978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
